Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diabetes Care|September 5, 2020
Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General PopulationElina Rautio, Fredrik Gadler, Soffia Gudbjörnsdottir, et al.
Cardiovascular Diabetology|December 30, 2025
Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort studyYiran Zhou, Elina Rautio, Per Näsman, et al.
Diabetes & Vascular Disease Research|March 23, 2021
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trialAnne Wang, Hertzel C Gerstein, Shun Fu Lee, et al.
Cardiovascular Diabetology|January 6, 2024
Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general populationElina Rautio, Fredrik Gadler, Soffia Gudbjörnsdottir, et al.
Cardiovascular Diabetology|August 24, 2023
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysisPeter Rossing, Stephen C Bain, Heidrun Bosch-Traberg, et al.
European Journal of Preventive Cardiology|December 21, 2018
Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trialAnne Wang, Stefan Arver, Kurt Boman, et al.
European Heart Journal|September 4, 2013
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial, Linda G Mellbin, Lars Rydén, et al.
Diabetes Care|December 6, 2023
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk FactorsElena Fortin, Beatrice Campi, Ele Ferrannini, et al.
Diabetes/Metabolism Research and Reviews|July 15, 2020
Effect of dipeptidyl peptidase-4 inhibitors on complement activationIngeborg T Hoffmann-Petersen, Charlotte B Holt, Lisbeth Jensen, et al.
Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.
Pageof 3